FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

733026001: Vial (unit of presentation)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498597013 Vial (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498598015 Vial en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vial Is a Unit of presentation true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely esomeprazole (as esomeprazole sodium) 40 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely flucloxacillin (as flucloxacillin sodium) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely flucloxacillin (as flucloxacillin sodium) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely risperidone 25 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely risperidone 25 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely risperidone 37.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely risperidone 37.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely risperidone 50 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely risperidone 50 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely octocog alfa 1000 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely octocog alfa 1000 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely octocog alfa 2000 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely octocog alfa 2000 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely inotuzumab ozogamicin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely inotuzumab ozogamicin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely ganciclovir (as ganciclovir sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely ganciclovir (as ganciclovir sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely ganciclovir (as ganciclovir sodium) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely ganciclovir (as ganciclovir sodium) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely ifosfamide 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely ifosfamide 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely ifosfamide 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely ifosfamide 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely pegvisomant 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely pegvisomant 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely exenatide 2 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely exenatide 2 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely normal human immunoglobulin 10 gram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely normal human immunoglobulin 10 gram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely olanzapine (as olanzapine embonate) 405 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely olanzapine (as olanzapine embonate) 405 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely olanzapine (as olanzapine embonate) 300 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely olanzapine (as olanzapine embonate) 300 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely olanzapine (as olanzapine embonate) 210 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely olanzapine (as olanzapine embonate) 210 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely tigecycline 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely tigecycline 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely tigecycline 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely tigecycline 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely thiotepa 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely thiotepa 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely terlipressin acetate 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely terlipressin acetate 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely teduglutide 1.25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely teduglutide 1.25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely tasonermin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely tasonermin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely trabectedin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely trabectedin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1
Product containing precisely trabectedin 250 microgram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation True Vial Inferred relationship Existential restriction modifier
Product containing precisely trabectedin 250 microgram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit True Vial Inferred relationship Existential restriction modifier 1

Start Previous Page 14 of 21 Next End


This concept is not in any reference sets

Back to Start